The biotechnology company entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 11,000 shares of series O, and 11,000 shares of series P redeemable convertible preferred stock at$952.38 per share.
The proceeds will be used for working capital and general corporate purposes, the company said.
Shares of AIkido declined 6.8% during the recent trading activity.
Price: 0.39, Change: -0.03, Percent Change: -6.75
|-- Earnings Flash (AQS) AEQUUS PHARMACEUTICALS Repor...|
|Insider Buy: Bitnile Holdings|
|Insider Buy: Macerich|
|Insider Sell: Velodyne Lidar|
|Insider Sell: Xometry|